Mostrar el registro sencillo del ítem
Breast milk microRNAs harsh journey towards potential effects in infant development and maturation. Lipid encapsulation can help
dc.contributor.author | Tomé-Carneiro J. | |
dc.contributor.author | Fernández-Alonso N. | |
dc.contributor.author | Tomás-Zapico C. | |
dc.contributor.author | Visioli F. | |
dc.contributor.author | Iglesias-Gutierrez E. | |
dc.contributor.author | Dávalos A. | |
dc.date.accessioned | 2020-09-02T22:29:16Z | |
dc.date.available | 2020-09-02T22:29:16Z | |
dc.date.issued | 2018 | |
dc.identifier | 10.1016/j.phrs.2018.04.003 | |
dc.identifier.citation | 132, , 21-32 | |
dc.identifier.issn | 10436618 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/6396 | |
dc.description | The possibility that diet-derived miRNAs survive the gastrointestinal tract and exert biological effects in target cells is triggering considerable research in the potential abilities of alimentary preventive and therapeutic approaches. Many validation attempts have been carried out and investigators disagree on several issues. The barriers exogenous RNAs must surpass are harsh and adequate copies must reach target cells for biological actions to be carried out. This prospect opened a window for previously unlikely scenarios concerning exogenous non-coding RNAs, such as a potential role for breast milk microRNAs in infants’ development and maturation. This review is focused on the thorny path breast milk miRNAs face towards confirmation as relevant role players in infants’ development and maturation, taking into consideration the research carried out so far on the uptake, gastrointestinal barriers and potential biological effects of diet-derived miRNAs. We also discuss the future pharmacological and pharma-nutritional consequences of appropriate miRNAs research. © 2018 Elsevier Ltd | |
dc.language.iso | en | |
dc.publisher | Academic Press | |
dc.subject | Breast milk | |
dc.subject | Diet | |
dc.subject | Exogenous | |
dc.subject | Exosome | |
dc.subject | miRNA | |
dc.subject | lipid | |
dc.subject | microRNA | |
dc.subject | microRNA 125b | |
dc.subject | microRNA 141 3p | |
dc.subject | microRNA 146b | |
dc.subject | microRNA 146b 5p | |
dc.subject | microRNA 148a | |
dc.subject | microRNA 155 | |
dc.subject | microRNA 156a | |
dc.subject | microRNA 159 | |
dc.subject | microRNA 159a | |
dc.subject | microRNA 168a | |
dc.subject | microRNA 169a | |
dc.subject | microRNA 17 | |
dc.subject | microRNA 181a | |
dc.subject | microRNA 181b | |
dc.subject | microRNA 182 5p | |
dc.subject | microRNA 191 5p | |
dc.subject | microRNA 200a 3p | |
dc.subject | microRNA 21 | |
dc.subject | microRNA 22 3p | |
dc.subject | microRNA 223 | |
dc.subject | microRNA 26a 5p | |
dc.subject | microRNA 2911 | |
dc.subject | microRNA 29a 3p | |
dc.subject | microRNA 30b 5p | |
dc.subject | microRNA 30d 5p | |
dc.subject | microRNA 92 | |
dc.subject | unclassified drug | |
dc.subject | unindexed drug | |
dc.subject | untranslated RNA | |
dc.subject | lipid | |
dc.subject | microRNA | |
dc.subject | breast milk | |
dc.subject | child development | |
dc.subject | colostrum | |
dc.subject | encapsulation | |
dc.subject | gene function | |
dc.subject | human | |
dc.subject | immune system | |
dc.subject | lactation | |
dc.subject | nonhuman | |
dc.subject | priority journal | |
dc.subject | Review | |
dc.subject | RNA sequence | |
dc.subject | RNA stability | |
dc.subject | RNA transport | |
dc.subject | sequence analysis | |
dc.subject | animal | |
dc.subject | bioavailability | |
dc.subject | child development | |
dc.subject | immunology | |
dc.subject | newborn | |
dc.subject | Animals | |
dc.subject | Biological Availability | |
dc.subject | Child Development | |
dc.subject | Humans | |
dc.subject | Infant, Newborn | |
dc.subject | Lipids | |
dc.subject | MicroRNAs | |
dc.subject | Milk, Human | |
dc.title | Breast milk microRNAs harsh journey towards potential effects in infant development and maturation. Lipid encapsulation can help | |
dc.type | Review |